RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding RenovoRx, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 12 | 11 | −1 |
| Shares | 164.8K | 1.19M | +1.02M (+621.1%) |
| Value | $482.0K | $2.35M | +$1.87M (+388.0%) |
New holders (2)
Institutions that held RenovoRx, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of the West | 975,000 | $1.93M | 0.24% |
| UBS Group AG | 6,217 | $12.0K | 0.00% |
Sold out (3)
Institutions that held RenovoRx, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 18,582 | $54.0K |
| Colony Group LLC | 15,508 | $45.0K |
| BlackRock Inc. | 429 | $1.00K |